Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients' Treatment Preferences For Muscle Invasive Bladder Cancer Cancer: A Discrete Choice Experiment

NCT05236218 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT05236218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05236218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients' Treatment Preferences For Muscle Invasive Bladder Cancer Cancer: A Discrete Choice Experiment
Lead sponsor
King's College London
Phase
Observational
Overall status
Unknown status
Start date
July 20, 2022
Completion date
January 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle invasive bladder cancer, patient preference, patient satisfaction, sexual wellbeing, surgery